Abbvie Inc. vs Glaukos Corporation
ABBV vs GKOS — side-by-side comparison from reported financials. ABBV leads 5, GKOS leads 3 of 8 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Glaukos Corporation
GKOS · Healthcare
$165.69+2.73%Strong
| Metric | ABBV | GKOS |
|---|---|---|
| Price | $276.43 | $165.69 |
| Market cap | $488B | $9.77B |
| Revenue (TTM) | $64.4B | $613M |
| Revenue growth | +1.8% | +21.5% |
| Net margin | 9.8% | -30.7% |
| Free cash flow | $18.2B | -$12.2M |
| Net cash (debt) | ($56.2B) | — |
| 1-year price return | +19.8% | +90.4% |
| P/E | 77.4 | — |
| P/E vs own history (cheap-side %) | 23% | — |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | -27% |
| Altman Z-score | 2.33 | 23.88 |
| CV checks passed | 9 of 11 | 4 of 11 |
| Employees | 57,000 | 1,094 |
Full résumé-style profiles: ABBV CV · GKOS CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.